Zhou, Y.; Wang, Y.; Liang, J.; Qian, J.; Wu, Z.; Gao, Z.; Qi, J.; Zhu, S.; Li, N.; Chen, Y.;
et al. Generation, Characterization, and Preclinical Studies of a Novel NKG2A-Targeted Antibody BRY805 for Cancer Immunotherapy. Antibodies 2024, 13, 93.
https://doi.org/10.3390/antib13040093
AMA Style
Zhou Y, Wang Y, Liang J, Qian J, Wu Z, Gao Z, Qi J, Zhu S, Li N, Chen Y,
et al. Generation, Characterization, and Preclinical Studies of a Novel NKG2A-Targeted Antibody BRY805 for Cancer Immunotherapy. Antibodies. 2024; 13(4):93.
https://doi.org/10.3390/antib13040093
Chicago/Turabian Style
Zhou, Yaqiong, Yiru Wang, Jinfeng Liang, Jing Qian, Zhenhua Wu, Zhangzhao Gao, Jian Qi, Shanshan Zhu, Na Li, Yao Chen,
and et al. 2024. "Generation, Characterization, and Preclinical Studies of a Novel NKG2A-Targeted Antibody BRY805 for Cancer Immunotherapy" Antibodies 13, no. 4: 93.
https://doi.org/10.3390/antib13040093
APA Style
Zhou, Y., Wang, Y., Liang, J., Qian, J., Wu, Z., Gao, Z., Qi, J., Zhu, S., Li, N., Chen, Y., Chen, G., Nie, L., Guo, T., & Wang, H.
(2024). Generation, Characterization, and Preclinical Studies of a Novel NKG2A-Targeted Antibody BRY805 for Cancer Immunotherapy. Antibodies, 13(4), 93.
https://doi.org/10.3390/antib13040093